Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

PS-341 (VELCADE™) Versus High-Dose Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma

ClinicalTrials.gov ID: NCT00048230

Public ClinicalTrials.gov record NCT00048230. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 18, 2026, 9:03 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

An International, Multi-Center, Randomized, Open-Label Study of PS-341 (VELCADE™) Versus High-Dose Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This study will compare the efficacy of PS-341 versus high dose dexamethasone.

Study identification

NCT ID
NCT00048230
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Enrollment
620 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
Not listed
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 2002 (Type not available)
Primary completion
Jul 2004 (Actual)
Completion
Dec 2004 (Actual)
Last update posted
Jan 13, 2012

2002 – 2004

United States locations

U.S. sites
39
U.S. states
20
U.S. cities
33
Facility City State ZIP Site status
Alta Bates Comprehensive Cancer Center Berkeley California 94704 —
City of Hope Duarte California 91010 —
Scripps Clinic La Jolla California 92307 —
Loma Linda University Medical Center Loma Linda California 92354 —
Kaiser Permanente Oncology Clinical Trials Vallejo California 94589 —
Lombardi Cancer Center, Georgetown University Medical Center Washington D.C. District of Columbia 20007 —
Med Star Institute, Washington Cancer Center Washington D.C. District of Columbia 20010 —
Hematology/Oncology Associates, PA Jacksonville Florida 32207 —
University of Miami Miami Florida 33136 —
H. Lee Moffitt Cancer Center, University of S. Florida Tampa Florida 33612 —
Emory University Atlanta Georgia 30322 —
Northwestern University Medical School Chicago Illinois 60611 —
Loyola University Medical Center: Cardinal Bernardin Cancer Center Maywood Illinois 60153 —
LSU HC Shreveport Louisiana 71130 —
Tufts New England Medical Center Boston Massachusetts 02111 —
Dana-Farber Cancer Center Boston Massachusetts 02115 —
Beth Israel Deaconess Medical Center, Kirstein Room 135 Boston Massachusetts 02215 —
Department of Internal Medicine, Univ. of Michigan Comp. Cancer Center Ann Arbor Michigan 48109-0922 —
VA Medical Center, Sections of Hematology/Oncology Minneapolis Minnesota 55417 —
Mayo Clinic Rochester Minnesota 55905 —
Washington University School of Medicine St Louis Missouri 63110 —
Hackensack University Medical Center, David Jurist Research Building Hackensack New Jersey 07601 —
Roswell Park Cancer Institute Buffalo New York 14263 —
Long Island Jewish Medical Center, Division of Hematology/Oncology New Hyde Park New York 11040 —
St. Vincent's Comprehensive Cancer Center, Research Department New York New York 10011 —
NY Presbyterian Hospital New York New York 10021 —
Rochester General Hospital, Lipson Cancer Blood Center Rochester New York 14621 —
University of Rochester Medical Center, James P. Wilmot Cancer Center Rochester New York 14642 —
Carolinas Hematology-Oncology Associates Charlotte North Carolina 28203 —
Cleveland Clinic Foundation Cleveland Ohio 44195 —
University of Pennsylvania Cancer Center Philadelphia Pennsylvania 19104 —
Western Pennsylvania Hospital, Dept. of Human Oncology Pittsburgh Pennsylvania 15224 —
Trident Palmetto Hematology/Oncology Charleston South Carolina 29406 —
Division of Hematology/Stem Cell Transplant Nashville Tennessee 37232-5505 —
Texas Oncology at Medical City Dallas Hospital Dallas Texas 75225 —
Baylor Institute for Immunology Research Dallas Texas 75246 —
MD Anderson Cancer Center Houston Texas 77030 —
Fred Hutchinson Cancer Center Seattle Washington 98109 —
Medical College of Wisconsin Milwaukee Wisconsin 53226 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 54 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00048230, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 13, 2012 · Synced Oct 18, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00048230 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →